New antibiotics developed with AI

[harm_less]

It will be interesting how this pans out. Apparently the pharmaceutical companies aren't prioritising antibiotic development because the returns are much lower than for other drugs such as for cancer, alzheimers and inflammatory conditions. Antibiotics also present a reducing return on development costs due to resistance occurring so quickly.

Greed takes precedence - yet again.

Or basic business sense in not developing a product whose useful life is so short as to prevent it breaking even before it is redundant.